Back to Results
First PageMeta Content
Pharmacology / Pharmaceutical industry / Cancer research / Epidemiology / Biomarker / Validation / Epidermal growth factor receptor / Food and Drug Administration / Clinical trial / Medicine / Health / Clinical research


Summary ReportA Blueprint for Drug/Diagnostic Co-Development: Next-Generation Sequencing (NGS) in Oncology TABLE OF CONTENTS 
Add to Reading List

Document Date: 2014-09-26 16:21:57

Open Document

File Size: 488,80 KB

Share Result on Facebook

Company

Qiagen / NGS Working Group / Vertex / /

Country

United States / /

Currency

pence / /

Event

FDA Phase / /

Facility

American College of Medical Genetics / American College of Obstetricians / /

IndustryTerm

interested / actionable cancer panel products / drug product / molecular technology / appropriate product / exempt products / diagnostic product / performance protocols / pharmaceutical / actionable cancer product / /

MedicalCondition

tumor / multiplex cancer / patient’s tumor / cancer / HIV / tumors / advanced squamous cell lung cancer / disease / NSCLC / HBV / NGS-based cancer / approved cancer / significant disease / broad cancer / largest academic cancer / HCV / lung cancer / actionable cancer / non-small cell lung cancer / hereditary information / actionable cancer NGS / Cystic Fibrosis / rare tumor / /

MedicalTreatment

investigational treatments / /

Organization

office of IVDs and Radiological Products / office of IVDs / US Food and Drug Administration / the American College / FDA / American College of Obstetricians and Gynecologists / Radiological Products / /

Position

driver / treating physician / /

Product

Kalydeco / MAP1 / UCM262327 / /

Technology

Genomics / underlying platform technologies / performance protocols / drug development / /

URL

http /

SocialTag